Breaking News
July 17, 2018 - Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
July 17, 2018 - Roots of leukemia reveal possibility of predicting people at risk
July 17, 2018 - Summer med program embraces low-income students’ potential
July 17, 2018 - New research lays foundation to create standards for RNA sequencing
July 17, 2018 - CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought
July 17, 2018 - Democrats rally against threats to the ACA to block Trump’s Supreme Court nominee
July 17, 2018 - Staggering prices slow insurers’ coverage of CAR-T cancer therapy
July 17, 2018 - How proteins involved in neurodegeneration enter cells
July 17, 2018 - New super-resolution ‘nanoscope’ provides insight into progression of Alzheimer’s disease
July 17, 2018 - FDA Advisory Committee Endorses the Effectiveness and Safety of Single-Dose Tafenoquine for the Radical Cure of P. vivax Malaria
July 17, 2018 - Uncovering the evolutionary history of IBD-associated colorectal cancer
July 17, 2018 - Is nutrition research dependable? Stanford’s John Ioannidis weighs in
July 17, 2018 - New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions
July 17, 2018 - Plant-based products fail to have positive impact on blood pressure during clinical studies
July 17, 2018 - Electronic system to speed up facial pain diagnosis may improve quality of life and save money
July 17, 2018 - Study delves into the role played by Protein Kinase C in synaptic plasticity
July 17, 2018 - Women Often Unaware of Their Hospital’s Religious Affiliation
July 17, 2018 - New AASM guideline recommends use of actigraphy for sleep disorders
July 17, 2018 - CRISPR editing reduces repetitive behavior in mice with a form of autism
July 17, 2018 - Scientists use magnets to detect cancer
July 17, 2018 - Microfluidic chip to detect sepsis proves successful in clinical study
July 17, 2018 - Research provides better understanding of mechanisms underlying memory storage
July 17, 2018 - A Multi-Modal Approach for the Early Detection of Breast Cancer
July 17, 2018 - Mailing colorectal cancer tests to patients increases screening rates, report researchers
July 17, 2018 - Scientists find possible sources of medicinal and antimicrobial drugs
July 17, 2018 - Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer
July 17, 2018 - Efficient communication between hospitals improves patient safety and reduces mortality
July 17, 2018 - Study highlights potential of fetal gene therapy to prevent lethal neurodegenerative disease
July 17, 2018 - For Americans, in Science They Trust
July 17, 2018 - Combating HIV/AIDS | NIH MedlinePlus the Magazine
July 17, 2018 - Study shows minorities widely underrepresented in autism diagnoses
July 17, 2018 - Multigene testing replacing BRCA tests for breast cancer risk | News Center
July 17, 2018 - Pre-clinical pilot study shows promising results of ‘concussion pill’
July 17, 2018 - Researchers reduce size of tumors in mice by artificially activating the brain’s reward system
July 17, 2018 - New study documents symptoms of people before they acquire multiple sclerosis
July 17, 2018 - Researchers discover why CRISPR gene editing sometimes fails
July 17, 2018 - New finding may hold key to better understand the complexities of neurological disorders
July 17, 2018 - The Current issue of “The view from here” is concerned with Novel Targets.
July 17, 2018 - Fighting the Flu with a Universal Vaccine
July 17, 2018 - Key social reward circuit in the brain impaired in kids with autism | News Center
July 17, 2018 - Insight into causes, types and treatment of aphasia
July 16, 2018 - Quark Pharmaceuticals, Inc Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
July 16, 2018 - NSAIDs shown to have causal role in cardiovascular risk of patients with osteoarthritis
July 16, 2018 - PET scan tracer predicts success of cancer ‘vaccine’ | News Center
July 16, 2018 - Parents struggle with what to do when their child has headache, shows study
July 16, 2018 - Outrageous or overblown? HHS announces another round of ACA navigator funding cuts
July 16, 2018 - Weight loss surgery may impact individual’s risk of developing cancer, shows study
July 16, 2018 - Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
July 16, 2018 - Restoring epigenetic balance reinstates memory in flies with Alzheimer’s disease symptoms
July 16, 2018 - Magnetized wire could be used to detect cancer in people | News Center
July 16, 2018 - Non-surgical management found to be feasible option for penetrating kidney trauma
July 16, 2018 - California clinic screens asylum seekers for honesty
July 16, 2018 - FDA Approves Xtandi (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
July 16, 2018 - Can nanotechnology help treat Alzheimer’s?
July 16, 2018 - Researchers identify protein essential for making stem cells | News Center
July 16, 2018 - Severe childhood infections linked with lower school achievement in adolescence
July 16, 2018 - Radiologist discusses causes, treatments of varicose veins
July 16, 2018 - Researchers develop nanostructured surface to accelerate wound healing after dental implants
July 16, 2018 - New non-invasive procedure to reposition kidney stones could benefit astronauts
July 16, 2018 - Attending Surgeon Influences Genetic Testing in Breast Cancer
July 16, 2018 - Medical doctors with addictions fear professional repercussions if they seek treatment
July 16, 2018 - 5 Questions: John Ioannidis calls for more rigorous nutrition research | News Center
July 16, 2018 - University of Illinois buys 3D-Bioplotter for regenerative biology, tissue engineering research
July 16, 2018 - Charité’s researchers integrate open-source platform into the ‘Human Brain Project’
July 16, 2018 - SUSU scientists develop rehabilitation device for people with lower limbs injuries
July 16, 2018 - Researchers find definite increase in scooter-related injuries
July 16, 2018 - Researchers solve mystery of final blood group system
July 16, 2018 - Researchers develop near-infrared fluorophores-based PDT to cure cancer with less side effects
July 16, 2018 - Traumatic brain injury biomarker could help predict patient prognosis
July 16, 2018 - Researchers to investigate role of hormones in mosquito’s ability to use human blood for egg production
July 16, 2018 - AHA: Doctor Makes Lifesaving House Call in His Own Home
July 16, 2018 - Nearsightedness – Genetics Home Reference
July 16, 2018 - Study shows biomarker panel boosts lung cancer risk assessment for smokers
July 16, 2018 - Researchers find link between bereavement during pregnancy, child’s mental health | News Center
July 16, 2018 - Legalizing same-sex marriage has meaningful effects on health care access for sexual-minority men
July 16, 2018 - New York to allow medical marijuana as substitute to opioids
July 16, 2018 - Reducing tapeworm infection could improve academic performance, reduce poverty | News Center
July 16, 2018 - Researchers describe key role of enzyme in regulating immune response against Chagas disease parasite
July 16, 2018 - Johnson & Johnson Announces Publication in The Lancet Highlighting Robust Immune Response to Janssen’s Mosaic-based Preventive Vaccine Regimen for HIV
July 16, 2018 - Do Racial and Gender Disparities Exist in Newer Glaucoma Treatments?
Biochemist, physicist team to see antibacterial TCS deform mitochondria

Biochemist, physicist team to see antibacterial TCS deform mitochondria

image_pdfDownload PDFimage_print
Credit: University of Maine

Grocery shopping can be an illuminating chore for a toxicologist.

Julie Gosse, a University of Maine associate professor of molecular and biomedical sciences, has scanned the supermarket aisles for products that contain triclosan (TCS), a synthetic antibacterial agent.

Since the ’90s, TCS has been in a slew of consumer products, including facial cleansers, toothpaste, mouthwash and hand sanitizers.

For years, Gosse has studied TCS, which for decades also has been used as a hospital scrub to reduce risk of infection.

She became interested in examining triclosan when listening to a talk by Environmental Protection Agency scientist Susan Richardson and noting that the molecular structure of TCS resembles the molecular structure of dioxins, which are toxic environmental pollutants.

In 2016, the Food and Drug Administration banned triclosan from consumer bar soaps, liquid soaps and body washes. At that time, the FDA challenged manufacturers to either prove TCS was more effective at killing germs than plain soap, or to remove it from their soap product within a year.

The antimicrobial agent, which is readily absorbed into the skin and the lining of the mouth, has recently been found to have detrimental effects on human fertility, development, thyroid function and immunology, and has been associated with increased occurrence of asthma.

Then, about six months ago, the FDA also announced a ban on products such as hand washes and antiseptic rubs containing TCS that are used in medical settings.

There’s no such ban on Colgate Total, the popular toothpaste that contains TCS. That’s because it’s been found to be more effective at treating gingivitis than toothpaste without it.

Gingivitis is an important health concern as it can lead to tooth loss. And research has indicated the bacteria that causes periodontitis can enter a person’s bloodstream and harm the heart and lungs.

Gosse understands why people with gingivitis would use Colgate Total; she just wants millions of people without gingivitis who also use the product to be aware of possible risks.

“Our job is to do the best science we can do and make people aware,” she says. “As scientists, we communicate our findings, and the public or companies or government decides what they should do.”

Triclosan also remains in certain “antibacterial” products not under the FDA’s control—such as cutting boards and baby products.

In various studies, Gosse and colleagues have made multiple discoveries about TCS. In conducting their research, they’ve used TCS dosages that correspond to doses people are exposed to when brushing their teeth or showering with products that contain the antimicrobial.

One discovery is that TCS is a mitochondrial uncoupler. That is, it’s toxic to mitochondria, which are the energy powerhouses of cells. When mitochondria are deformed or shut down, they can’t make the energy that cells need to perform functions—including immune defense.

One study outside of UMaine found increased TCS levels in mothers of babies with birth defects. Another study, also outside of UMaine, indicated mitochondrial dysfunction was linked to cognitive decline in monkeys.

Gosse determined TCS is 30 to 60 times more toxic than 2,4-dinitrophenol, another uncoupler once used in diet drugs (and to make explosives) that was banned in the late 1930s because it resulted in death or severe side effects.

In UMaine’s most recent study, the team sought to determine the mechanisms underlying TCS disruption of mitochondrial function and mast cell signaling.

To do so, Gosse and her doctoral student Lisa Weatherly teamed with professor of physics Sam Hess and his doctoral student Andrew Nelson.

Hess invented a fluorescence photoactivation localization microscopy (FPALM) technique that allows researchers to witness triclosan’s deformation of live cells’ mitochondria, in real time.

Mitochondria are generally an elongated oval shape. TCS either deforms mitochondria from an oval to a doughnut shape or breaks up the energy powerhouses, within minutes.

Gosse has pored through conference proceedings and publications and believes the UMaine team is the first to use super-resolution microscopy work in the field of toxicology.

Following up on the microscope findings, Gosse and her team determined the biochemical mechanisms that underlie triclosan’s fission of mitochondria—including generation of damaging reactive oxygen species.

TCS, says Gosse, also inhibits cellular cytoskeletons, which are microscopic networks of protein filaments and tubules in the cytoplasm of living cells. Cytoskeletons help the cell move, transport cargo, and carry out many other tasks essential for health.

When TCS inhibits cytoskeletons, it inhibits mast cell function. Mast cells are part of the immune and nervous systems that, when stimulated, release chemicals that play many roles in the body, including antimicrobial defense, cancer and even emotional regulation.

Mast cells are in most human tissues, including the lining of the mouth and in skin—both of which absorb TCS. So, when mast cells are inhibited, problems may arise.

The Gosse lab also found that, of several cell types tested, primary human skin cells were the cells most harmed by TCS.

The UMaine team’s most recent findings were published in April in the article “Antimicrobial agent triclosan disrupts mitochondrial structure, revealed by super-resolution microscopy, and inhibits mast cell signaling via calcium modulation” in Toxicology and Applied Pharmacology.

In addition to Gosse, Hess, Weatherly and Nelson, UMaine researchers participating in the study included graduate students Juyoung Shim and Andrew Hart and undergraduates Erik Gerson and Abigail Riitano; as well as Timothy Ryan and Jaime de Juan-Sanz of Weill Cornell Medicine; and Roger Sher of Stony Brook University.

Funding was provided by an R15 Academic Research Enhancement Award which supports meritorious research and exposes undergraduate and graduate students to hands-on research—from the National Institutes of Health. Graduate School of Biomedical Science and Engineering student Weatherly was supported by UMaine’s Chase Distinguished Research Assistantship and Michael J. Eckardt Dissertation Fellowship.

Thanks to research conducted by Gosse and other scientists, consequences of exposure to triclosan are becoming better understood and known.

And thanks to Hess’ FPALM technique, the field of toxicology has a powerful new tool for understanding chemical effects on human health.

Triclosan, though, is one of about 80,000 synthetic chemicals that people are regularly exposed to, says Gosse. And many of their long-term effects have not been studied.


Explore further:
Common antimicrobial inhibits immune cell function

More information:
Lisa M. Weatherly et al. Antimicrobial agent triclosan disrupts mitochondrial structure, revealed by super-resolution microscopy, and inhibits mast cell signaling via calcium modulation, Toxicology and Applied Pharmacology (2018). DOI: 10.1016/j.taap.2018.04.005

Journal reference:
Toxicology and Applied Pharmacology

Provided by:
University of Maine

Tagged with:

About author

Related Articles